Phase 2 SCLC,Extensive Stage Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation44 enrolled18 locationsNCT05718323
Recruiting
Phase 1Phase 2
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
SCLCSmall Cell Lung CancerSCLC,Extensive Stage+2 more
Peking University First Hospital30 enrolled1 locationNCT07508852
Recruiting
Phase 1Phase 2
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
SCLC,Extensive StageSmall Cell Lung Cancer ( SCLC )Relapsed/Refractory SCLC
Beijing Biotech60 enrolled1 locationNCT07480213
Recruiting
Phase 2
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
SCLCSCLC,Extensive Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences20 enrolled2 locationsNCT07110103
Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
Advanced Solid TumorsSCLC,Extensive Stage
Shanghai AB PharmaTech Ltd.110 enrolled8 locationsNCT07321574
Recruiting
Phase 2
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
SCLC,Extensive Stage
Tang-Du Hospital32 enrolled1 locationNCT07141264
Recruiting
Phase 1Phase 2
Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
SCLC,Extensive Stage
Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.27 enrolled2 locationsNCT07136285
Recruiting
Phase 2
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
SCLC,Extensive Stage
Shanghai Henlius Biotech26 enrolled1 locationNCT06812260
Recruiting
Phase 2
Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)
SCLC,Extensive Stage
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS60 enrolled12 locationsNCT05623319
Recruiting
Phase 1Phase 2
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Brain MetastasesSCLC,Extensive Stage
Fudan University56 enrolled1 locationNCT06243003